| Mrs Paula Marie Pino, RN | |
|
2798 Whistler St, Melbourne, FL 32904-7487 | |
| (321) 543-8076 | |
| Not Available |
| Full Name | Mrs Paula Marie Pino |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Continuing Education/staff Development |
| Location | 2798 Whistler St, Melbourne, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033468004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1600X | Registered Nurse - Continuing Education/staff Development | RN2060212 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Paula Marie Pino, RN 2798 Whistler St, Melbourne, FL 32904-7487 Ph: (321) 543-8076 | Mrs Paula Marie Pino, RN 2798 Whistler St, Melbourne, FL 32904-7487 Ph: (321) 543-8076 |
News Archive
The number of people living in high-rise buildings in rising, but along with the convenience and panoramic views of a downtown condo comes a risk: a new study found that survival rates from cardiac arrest decrease the higher up the building a person lives.
A fruitful collaboration between chemists and biologists has made it possible to identify the effects of a new class of molecules, polyoxometalates, primarily composed of metals and oxygen.
A Link between the level of active DNA repair genes in melanoma tumours and the effectiveness of chemotherapy for skin cancer patients has been established for the first time by a team of scientists.The study, part-funded by Cancer Research UK and published in Clinical Cancer Research today (Friday), found that higher levels of DNA repair genes in melanoma tumours were associated with a poorer response to chemotherapy.
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced results of its Phase 1 study of intravenous (IV) solithromycin in healthy subjects. The study demonstrated that IV solithromycin was well tolerated, showed a favorable pharmacokinetic profile (PK) and achieved relevant plasma concentrations.
Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).
› Verified 3 days ago
Mrs. Elaine E. Toth, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1900 S Harbor City Blvd Ste 232, Melbourne, FL 32901 Phone: 321-216-2288 Fax: 321-216-2255 | |
Mr. Mary Frances Hibbard, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1350 S Hickory St, Holmes Regional Medical Center (healthfirst), Melbourne, FL 32901 Phone: 321-434-7000 | |
Susan Bernard, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1344 S Apollo Blvd, Ste 100, Melbourne, FL 32901 Phone: 321-951-3223 Fax: 321-727-9448 | |
Andrea Sue Cohn, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 Luminary Cir Unit 106, Melbourne, FL 32901 Phone: 305-965-7820 | |
Julie Marie Crossett, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 N Wickham Rd Ste 102, Melbourne, FL 32935 Phone: 321-541-1777 | |
Ms. Michele Leone, RNFA, LMHC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2850 Washingtonia Dr, Melbourne, FL 32934 Phone: 321-213-9538 |